For this purpose, either anaemia with haematocrit values of about 25% was induced in PDGFR‐β cell‐type specific PHD3‐deficient mice and in control mice or the respective mice were treated with a series of three doses of the PHDi roxadustat. The gene discussed is EGLN3; the disease is anemia.